The Impact of Proton Pump Inhibitors on the Efficacy of Immune Checkpoint Inhibitor Combinations in Patients with HBV-Associated Advanced Hepatocellular Carcinoma
Article in Journal of Hepatocellular Carcinoma (July 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress
Article in Frontiers in Pharmacology (June 2024)
The occurrence of immune-related adverse events is an independent risk factor both for serum HBsAg increase and HBV reactivation in HBsAg-positive cancer patients receiving PD-1 inhibitor combinational therapy
Article in Frontiers in Immunology (March 2024)